Legacy Advisors’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-73,259
Closed -$579K 107
2025
Q1
$579K Sell
73,259
-27,468
-27% -$338K 0.06% 241
2024
Q4
$791K Sell
100,727
-3,543
-3% -$17.8K 0.08% 194
2024
Q3
$328K Sell
104,270
-4,101
-4% -$12.1K 0.04% 286
2024
Q2
$307K Buy
108,371
+76,394
+239% +$545K 0.04% 253
2024
Q1
$504K Buy
31,977
+7,675
+32% +$130K 0.06% 205
2023
Q4
$478K Buy
24,302
+5,477
+29% +$95.1K 0.06% 201
2023
Q3
$383K Buy
18,825
+937
+5% +$23.6K 0.06% 208
2023
Q2
$523K Buy
17,888
+847
+5% +$23.2K 0.08% 169
2023
Q1
$479K Buy
17,041
+1,233
+8% +$31.7K 0.09% 152
2022
Q4
$293K Buy
+15,808
New +$271K 0.05% 191

Other funds holding CRNC

Legacy Advisors's CRNC Position: Q2 2025 in Review

Legacy Advisors sold out of Cerence (CRNC) in Q2 2025, closing a stake of 73,259 shares — an estimated $579K sold.

Legacy Advisors first reported a position in CRNC in Q4 2022 and held it in 10 quarters. The position peaked at $791K in Q4 2024. 173 funds tracked by Wall St. Rank hold CRNC as of Q2 2025.

  • Legacy Advisors reported no remaining Cerence position as of Q2 2025 after selling out during the quarter.
  • Legacy Advisors sold 73,259 Cerence shares in Q2 2025, an estimated $579K.
  • Legacy Advisors first reported a position in Cerence in Q4 2022 and held it in 10 quarters.
  • Legacy Advisors's Cerence position peaked at $791K in Q4 2024.
  • 173 funds tracked by Wall St. Rank held Cerence as of Q2 2025.

Based on Legacy Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.